Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer

Radiotherapy and Oncology

Volumn 110, Issue 2, 2014, Pages 291-297

  Stenmark, Matthew H ^a,b   Conlon, Anna S C ^a   Johnson, Skyler ^a   Daignault, Stephanie ^a   Litzenberg, Dale ^a   Marsh, Robin ^a   Ritter, Timothy ^a,b   Vance, Sean ^c   Kazzi, Nayla ^a   Feng, Felix Y ^a   Sandler, Howard ^d   Sanda, Martin G ^e   Hamstra, Daniel A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

Patient reported; Prostate cancer; Quality of life; Radiation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION URGENCY; DETERIORATION; EXPANDED PROSTATE CANCER INDEX COMPOSITE; EXTERNAL BEAM RADIOTHERAPY; FECES INCONTINENCE; FIDUCIAL MARKER; GLEASON SCORE; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; IMAGE GUIDED RADIOTHERAPY; INFERIOR RECTUM; INSTITUTIONAL REVIEW; INTENSITY MODULATED RADIATION THERAPY; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PATIENT HISTORY OF SURGERY; PELVIS LYMPH NODE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTITIS; PROSPECTIVE STUDY; PROSTATE; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE DISTRIBUTION; RANDOMIZED CONTROLLED TRIAL; RECTUM; RECTUM HEMORRHAGE; SELF REPORT; SEMINAL VESICLE; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; GASTROINTESTINAL HEMORRHAGE; PATHOPHYSIOLOGY; PROSTATIC NEOPLASMS; RADIATION DOSE; RADIATION INJURIES; RADIATION RESPONSE; RECTAL DISEASES; STATISTICAL MODEL;

AGED; COHORT STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LINEAR MODELS; MALE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RECTAL DISEASES; RECTUM;

EID: 84896402773     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.01.007     Document Type: Article

References (32)

1. J.M. Michalski, K. Winter, and J.A. Purdy et al. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V Int J Radiat Oncol Biol Phys 62 2005 706 713 (Pubitemid 40779758)
2. J.D. Fenwick, V.S. Khoo, A.E. Nahum, B. Sanchez-Nieto, and D.P. Dearnaley Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer Int J Radiat Oncol Biol Phys 49 2001 473 480 (Pubitemid 32120245)
3. C. Fiorino, G. Fellin, and T. Rancati et al. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study Int J Radiat Oncol Biol Phys 70 2008 1130 1137 (Pubitemid 351296107)
4. C. Greco, C. Mazzetta, and F. Cattani et al. Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer Radiother Oncol 69 2003 215 222 (Pubitemid 37485883)
5. E.H. Huang, A. Pollack, and L. Levy et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 54 2002 1314 1321 (Pubitemid 35380030)
6. A. Jackson, M.W. Skwarchuk, and M.J. Zelefsky et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms Int J Radiat Oncol Biol Phys 49 2001 685 698 (Pubitemid 32112195)
7. C. Vargas, A. Martinez, and L.L. Kestin et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy Int J Radiat Oncol Biol Phys 62 2005 1297 1308 (Pubitemid 40982047)
8. S. Wachter, N. Gerstner, G. Goldner, R. Potzi, A. Wambersie, and R. Potter Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors Radiother Oncol 59 2001 65 70 (Pubitemid 32261078)
9. S.M. Bentzen, L.S. Constine, and J.O. Deasy et al. Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues Int J Radiat Oncol Biol Phys 76 2010 S3 S9
10. P.L. Nguyen, R.C. Chen, and K.E. Hoffman et al. Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial Int J Radiat Oncol Biol Phys 78 2010 1081 1085
11. D.A. Hamstra, A.S. Conlon, and S. Daignault et al. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience Int J Radiat Oncol Biol Phys 86 2013 546 553
12. M.G. Sanda, R.L. Dunn, and J. Michalski et al. Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261 (Pubitemid 351439226)
13. W.D. Heemsbergen, M.S. Hoogeman, G.A. Hart, J.V. Lebesque, and P.C. Koper Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy Int J Radiat Oncol Biol Phys 61 2005 1011 1018 (Pubitemid 40340896)
14. P.C. Koper, W.D. Heemsbergen, and M.S. Hoogeman et al. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer Int J Radiat Oncol Biol Phys 58 2004 1072 1082 (Pubitemid 38314788)
15. D. Vordermark, M. Schwab, R. Ness-Dourdoumas, M. Sailer, M. Flentje, and O. Koelbl Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate Radiother Oncol 69 2003 209 214 (Pubitemid 37485882)
16. J.T. Wei, R.L. Dunn, M.S. Litwin, H.M. Sandler, and M.G. Sanda Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899 905
17. D. Litzenberg, L.A. Dawson, and H. Sandler et al. Daily prostate targeting using implanted radiopaque markers Int J Radiat Oncol Biol Phys 52 2002 699 703 (Pubitemid 34158732)
18. T.R. Willoughby, P.A. Kupelian, and J. Pouliot et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer Int J Radiat Oncol Biol Phys 65 2006 528 534
19. H.A. Gay, H.J. Barthold, and E. O'Meara et al. Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas Int J Radiat Oncol Biol Phys 83 2012 e353 e362
20. F. Buettner, S.L. Gulliford, S. Webb, M.R. Sydes, D.P. Dearnaley, and M. Partridge The dose-response of the anal sphincter region - an analysis of data from the MRC RT01 trial Radiother Oncol 103 2012 347 352
21. D.A. Hamstra, M.H. Stenmark, and T. Ritter et al. Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 85 2013 1246 1253
22. J.M. Michalski, H. Gay, A. Jackson, S.L. Tucker, and J.O. Deasy Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 2010 S123 S129
23. H. Akaike A new look at statistical model identification IEEE Trans Automat Contr 19 1974 716 722
24. G. Glatting, P. Kletting, S.N. Reske, K. Hohl, and C. Ring Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test Med Phys 34 2007 4285 4292 (Pubitemid 350029650)
25. A. Pollack, G.K. Zagars, and G. Starkschall et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105 (Pubitemid 34787842)
26. M. Al-Abany, A.R. Helgason, and A.K. Cronqvist et al. Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum Int J Radiat Oncol Biol Phys 61 2005 1035 1044 (Pubitemid 40340898)
27. S.T. Peeters, J.V. Lebesque, and W.D. Heemsbergen et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 64 2006 1151 1161
28. S.L. Gulliford, K. Foo, and R.C. Morgan et al. Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397 Int J Radiat Oncol Biol Phys 76 2010 747 754
29. S.L. Tucker, L. Dong, and J.M. Michalski et al. Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06 Int J Radiat Oncol Biol Phys 84 2012 390 395
30. J.M. Michalski, Y. Yan, S. Tucker, K. Winter, W. Bosch, and J. Galvin et al. Dose volume analysis of grade 2+ late GI toxicity on RTOG 0126 after high-dose 3DCRT or IMRT Int J Radiat Oncol Biol Phys 84 2012 S14 S15
31. E.K. Yeoh, R.H. Holloway, R.J. Fraser, R.J. Botten, A.C. Di Matteo, and J. Butters Pathophysiology and natural history of anorectal sequelae following radiation therapy for carcinoma of the prostate Int J Radiat Oncol Biol Phys 84 2012 e593 e599
32. P.C.M. Koper, J.C. Stroom, and W.L. van Putten et al. Acute morbitidy reduction using 3DCRT for prostate carcinoma: a randomized study Int J Radiat Oncol Biol Phys 43 1999 727 734 (Pubitemid 29152645)